The treatment resulted in a reduction in duration of the acute period of atopic dermatitis, urticaria, and angioedema, a decrease in the level of specific IgE to cow’s milk proteins in children with atopic dermatitis, and an improvement in the state of the gastrointestinal canal with the decreasing of dysbiosis symptoms. This evidence concerns the gene IGHE and atopic eczema.